Mu J, Li R, Zheng Y, Lu Y, Ma L, Yin L
Stem Cell Res Ther. 2024; 15(1):296.
PMID: 39256886
PMC: 11389492.
DOI: 10.1186/s13287-024-03917-8.
Wasserman J, Fowle H, Hashmi R, Atar D, Patel K, Yarmahmoodi A
Sci Rep. 2024; 14(1):20409.
PMID: 39223207
PMC: 11369182.
DOI: 10.1038/s41598-024-71306-5.
Wasserman J, Fowle H, Hashmi R, Atar D, Patel K, Yarmahmoodi A
Res Sq. 2024; .
PMID: 38766032
PMC: 11100872.
DOI: 10.21203/rs.3.rs-4294058/v1.
Tang D
Semin Cancer Biol. 2021; 82:68-93.
PMID: 34844845
PMC: 9106849.
DOI: 10.1016/j.semcancer.2021.11.001.
Li F, Lu T, Liu D, Zhang C, Zhang Y, Dong F
Cell Death Dis. 2021; 12(6):528.
PMID: 34023860
PMC: 8141057.
DOI: 10.1038/s41419-021-03820-7.
Immortalization of human primary prostate epithelial cells via CRISPR inactivation of the CDKN2A locus and expression of telomerase.
Zhao Z, Fowle H, Valentine H, Liu Z, Tan Y, Pei J
Prostate Cancer Prostatic Dis. 2020; 24(1):233-243.
PMID: 32873916
PMC: 7917161.
DOI: 10.1038/s41391-020-00274-4.
Tumor Dormancy and Slow-Cycling Cancer Cells.
Davis Jr J, Kirk J, Ji Y, Tang D
Adv Exp Med Biol. 2019; 1164:199-206.
PMID: 31576550
PMC: 8025565.
DOI: 10.1007/978-3-030-22254-3_15.
Advances in prostate cancer research models: From transgenic mice to tumor xenografting models.
Huang Y, Cheng C, Zhang C, Zhang Y, Chen M, Strand D
Asian J Urol. 2017; 3(2):64-74.
PMID: 29264167
PMC: 5730804.
DOI: 10.1016/j.ajur.2016.02.004.
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors that Can Function as a Cell of Origin for Prostate Cancer.
Zhang D, Lin K, Lu Y, Rycaj K, Zhong Y, Chao H
Stem Cells Transl Med. 2017; 6(3):748-760.
PMID: 28297567
PMC: 5442765.
DOI: 10.5966/sctm.2016-0243.
Polyunsaturated fatty acids ameliorate aging via redox-telomere-antioncogene axis.
Chen J, Wei Y, Chen X, Jiao J, Zhang Y
Oncotarget. 2016; 8(5):7301-7314.
PMID: 28038469
PMC: 5352322.
DOI: 10.18632/oncotarget.14236.
Low p16 Expression in Early Passage Human Prostate Basal Epithelial Cells Enables Immortalization by Telomerase Expression Alone.
Graham M, Principessa L, Antony L, Meeker A, Isaacs J
Prostate. 2016; 77(4):374-384.
PMID: 27859428
PMC: 5548187.
DOI: 10.1002/pros.23276.
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer.
Zhang D, Park D, Zhong Y, Lu Y, Rycaj K, Gong S
Nat Commun. 2016; 7:10798.
PMID: 26924072
PMC: 4773505.
DOI: 10.1038/ncomms10798.
Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells.
Liu X, Chen X, Rycaj K, Chao H, Deng Q, Jeter C
Oncotarget. 2015; 6(27):23959-86.
PMID: 26246472
PMC: 4695164.
DOI: 10.18632/oncotarget.4260.
Tumor-suppressive functions of 15-Lipoxygenase-2 and RB1CC1 in prostate cancer.
Suraneni M, Moore J, Zhang D, Badeaux M, Macaluso M, DiGiovanni J
Cell Cycle. 2014; 13(11):1798-810.
PMID: 24732589
PMC: 4111726.
DOI: 10.4161/cc.28757.
Early human prostate adenocarcinomas harbor androgen-independent cancer cells.
Finones R, Yeargin J, Lee M, Kaur A, Cheng C, Sun P
PLoS One. 2013; 8(9):e74438.
PMID: 24086346
PMC: 3783414.
DOI: 10.1371/journal.pone.0074438.
Anti-tumor effect of 5-aza-2'-deoxycytidine by inhibiting telomerase activity in hepatocellular carcinoma cells.
Tao S, Zhang C, Guo X, Xu Y, Zhang S, Song J
World J Gastroenterol. 2012; 18(19):2334-43.
PMID: 22654424
PMC: 3353367.
DOI: 10.3748/wjg.v18.i19.2334.
The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.
Qin J, Liu X, Laffin B, Chen X, Choy G, Jeter C
Cell Stem Cell. 2012; 10(5):556-69.
PMID: 22560078
PMC: 3348510.
DOI: 10.1016/j.stem.2012.03.009.
Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor.
Beltran A, Rivenbark A, Richardson B, Yuan X, Quian H, Hunt J
Breast Cancer Res. 2011; 13(5):R94.
PMID: 21952072
PMC: 3262206.
DOI: 10.1186/bcr3019.
Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms.
Yan H, Chen X, Zhang Q, Qin J, Li H, Liu C
PLoS One. 2011; 6(9):e24397.
PMID: 21935404
PMC: 3174165.
DOI: 10.1371/journal.pone.0024397.
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H
Nat Med. 2011; 17(2):211-5.
PMID: 21240262
PMC: 3076220.
DOI: 10.1038/nm.2284.